Healthcare - Biotechnology - NASDAQ - NL
$ 24.9
-0.28 %
$ 2.3 B
Market Cap
-11.27
P/E
Price Target
Average
46.59%
Revenue Forecast
Estimate
137.06%
EBIT
Estimate
26.82%
Net Income
Estimate
19.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NewAmsterdam Pharma Company N.V.
Wall Street analysts predict an average 1-year price target for NAMS of $36.5 , with forecasts ranging from a low of $36 to a high of $37 .
NAMS Lowest Price Target
Wall Street Target
36 USD
44.58%
NAMS Average Price Target
Wall Street Target
36.5 USD
46.59%
NAMS Highest Price Target
Wall Street Target
37 USD
48.59%
REVENUE FORECAST
Revenue Forecast Chart NAMS
EBIT FORECAST
EBIT Forecast Chart NAMS
NET INCOME FORECAST
Net Income Chart NAMS